A new study published in The New England Journal of Medicine showed that daily dapagliflozin dramatically reduced the risk of ...

AstraZeneca PLC ( NASDAQ: AZN) Q2 2025 Earnings Conference Call July 29, 2025 9:00 AM ET ...

Baxdrostat is a highly selective, second-generation, nonimidazole aldosterone synthase inhibitor; 100 times less baxdrostat ...

On 21 July 2025, the Court of Appeal delivered a significant ruling in AstraZeneca AB & Anor v Generics (UK) Limited & Ors, addressing the pharmaceutical company's attempt to secure interim protection ...

Market Implications: The progress of this study could positively impact AstraZeneca’s stock performance by demonstrating the effectiveness of dapagliflozin in a new patient demographic.

Today, AstraZeneca Canada and Plan International Canada are excited to announce 10 exceptional young leaders selected to join the 2025-2026 Eureka Fellowship for Youth Changemakers in Canada ...

Today, AstraZeneca Canada and Plan International Canada are excited to announce 10 exceptional young leaders selected to join the 2025-2026 Eureka Fellowship for Youth Changemakers in Canada (Eureka ...

TORONTO, July 17, 2025 /CNW/ - Today, AstraZeneca Canada and Plan International Canada are excited to announce 10 exceptional young leaders selected to join the 2025-2026 Eureka Fellowship for ...

Top Losers Today: The stock market saw gains on June 20th. By noon, the Sensex had jumped 661 points, while the Nifty was up 192 points. During this time, AstraZeneca's stock fell by about 3%. Let ...